I’ve been watching this stock for the last six months...haven’t felt comfortable enough to jump in. Don’t know when I will. Sounds like PN doesn’t care much about the investor. The idea that his real motive in performing the R/S was to generate more cash by diluting the stock yet again raises caution. Who knows when a good time will be. This thing could easily go below a dollar again. Then we are back to a possible R/S again. I’ve Heard that possible completion of phase 2 could be as early as June, but as much as three more years? It all depends on the availability of test patients... which can be hard to come by. If it is only another four months, dilution will be minimal, but if it’s another three years it can become a major problem for shareholder value.
I’m excited in the fact that this seems to be a legitimate breakthrough in treating cancer and has great potential. I can’t quite understand why he chose a reverse split over having a group go out and promote the stock in order to raise share price. Maybe the cost associated with this was too great. I’ve got a friend that has been in the stock for over seven years and is still confident that it is not a matter of if, but when.
I’m sure PN assumes that his technology will be worth billions if proven successful and will reward investors at some point, it’s just hard to know exactly when and how much the stock, that each person holds will be worth by the time it happens.
